default author photo

Ning Li

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Clinical Trial Center

Beijing

China

SCHOLARLY PAPERS

4

DOWNLOADS

289

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

How to Design Next-Generation of Antibody-Drug Conjugates for Cancer Treatment: Lessons from Unsuccessful Clinical Trials

Number of pages: 12 Posted: 25 Nov 2024
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Clinical Trial Center
Downloads 101 (684,672)

Abstract:

Loading...

Antibody-drug conjugates (ADCs), Targeted drug delivery, ADC design optimization, Clinical trial termination factors.

2.

Global Divergence in Esophageal Cancer and Gastroesophageal Reflux Disease Burden: Temporal Dynamics, Regional Disparities, and Epidemiologic Associations

Number of pages: 27 Posted: 10 Jun 2025
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - China National Cancer Center/Cancer Hospital, Beihang University (BUAA) - School of Reliability and Systems Engineering, Chinese Academy of Medical Sciences - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Institute of Basic Medical Sciences, Beihang University (BUAA) - School of Reliability and Systems Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, China Medical University - First Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Tianjin Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Clinical Trial Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Beihang University (BUAA) - School of Reliability and Systems Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Clinical Trial Center and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery
Downloads 77 (823,616)

Abstract:

Loading...

Esophageal cancer, Gastroesophageal reflux disease, Global burden of disease, Time-series modeling and forecasting, Risk factor clustering, Temporal association analysis

3.

The Burden of Rare Tumors in China: Results of a Population-Study

Number of pages: 28 Posted: 20 Jan 2022
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - National Central Cancer Registry, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Clinical Trial Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Clinical Trial Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Clinical Trial Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - National Central Cancer Registry, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - National Central Cancer Registry, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Clinical Trial Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Clinical Trial Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Clinical Trial Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Clinical Trial Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - National Central Cancer Registry, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - National Central Cancer Registry, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - National Central Cancer Registry, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Clinical Trial Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital and Chinese Academy of Medical Sciences & Peking Union Medical College - Thoracic Surgery Department
Downloads 59 (970,490)

Abstract:

Loading...

Rare tumors, Incidence rate, Cancer survival, Cancer burden, China

4.

Phase II Trial of Neoadjuvant Camrelizumab and Apatinib in Resectable NSCLC: 3-Year Survival Outcomes and Dynamic Circulating Tumor DNA Analyses

Number of pages: 36 Posted: 13 Aug 2025
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Clinical Trial Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Tianjin Medical University - National Clinical Research Center for Cancer, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chinese Academy of Medical Sciences - National Cancer Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Clinical Trial Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery
Downloads 52 (1,041,696)

Abstract:

Loading...

non-small-cell lung cancer, neoadjuvant, camrelizumab, apatinib, survival